Overview A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients Status: Completed Trial end date: 2012-04-28 Target enrollment: Participant gender: Summary This study is to evaluate the efficacy and safety after concomitant administration of ASP1941 and pioglitazone in patients with diabetes mellitus. Phase: Phase 3 Details Lead Sponsor: Astellas Pharma IncTreatments: IpragliflozinPioglitazone